0% found this document useful (0 votes)
287 views46 pages

Foundations in Microbiology: Microbe-Human Interactions: Infection and Disease Talaro

Uploaded by

Odur
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
287 views46 pages

Foundations in Microbiology: Microbe-Human Interactions: Infection and Disease Talaro

Uploaded by

Odur
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 46

Lecture PowerPoint to accompany

Foundations in
Microbiology
Sixth Edition

Talaro
Chapter 13
Microbe-Human
Interactions: Infection
and Disease
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Contact, Colonization, Infection, Disease
• Microbes that engage in mutual or commensal
associations - normal (resident) flora,
indigenous flora, microbiota
• Infection- a condition in which pathogenic
microbes penetrate host defenses, enter tissues
and multiply
• Disease – any deviation from health, disruption
of a tissue or organ
• Caused by microbes or their products –
infectious disease
2
3
Resident Flora
• Includes bacteria, fungi, protozoa, viruses and
arthropods
• Most areas of the body in contact with the outside
environment harbor resident microbes; large
intestine has the highest numbers of bacteria.
• Internal organs and tissues and fluids are microbe-
free.
• Bacterial flora benefit host by preventing
overgrowth of harmful microbes – microbial
antagonism.
4
Initial Colonization of the Newborn
• Uterus and contents are normally sterile and
remain so until just before birth.
• Breaking of fetal membrane exposes the
infant; all subsequent handling and feeding
continue to introduce what will be normal
flora.

5
6
Major Factors in the Development of
an Infection
• True pathogens – capable of causing disease in
healthy persons with normal immune defenses
– influenza virus, plague bacillus, malarial
protozoan
• Opportunistic pathogens – cause disease when
the host’s defenses are compromised or when they
grow in part of the body that is not natural to them
– Pseudomonas sp & Candida albicans
• Severity of the disease depends on the virulence
of the pathogen; characteristic or structure that
contributes to the ability of a microbe to cause
disease is a virulence factor. 7
Insert text art page 388
Course of infection

Portals of entry – characteristic route a microbe follows


to enter the tissues of the body
– skin - nicks, abrasions, punctures, incisions
– gastrointestinal tract – food, drink, and other ingested
materials
– respiratory tract – oral and nasal cavities
– urogenital tract – sexual, displaced organisms
– transplacental
• Exogenous agents originate from source outside the
body.
• Endogenous agents already exist on or in the body
(normal flora).
8
Requirement for an Infectious Dose (ID)
• Minimum number of microbes required for
infection to proceed
• Microbes with small IDs have greater
virulence.
• Lack of ID will not result in infection.

9
10
Attaching to the Host
• Adhesion – microbes gain a stable foothold at the
portal of entry; dependent on binding between
specific molecules on host and pathogen
– fimbrae
– flagella
– adhesive slimes or capsules
– cilia
– suckers
– hooks
– barbs

11
12
Surviving Host Defenses
• Initial response of host defenses comes from
phagocytes.
• Antiphagocytic factors – used to avoid
phagocytosis
• Species of Staphylococcus and Streptococcus
produce leukocidins, toxic to white blood cells.
• Slime layer or capsule – makes phagocytosis
difficult
• Ability to survive intracellular phagocytosis
13
Causing Disease
• Virulence factors – traits used to invade and
establish themselves in the host, also determine
the degree of tissue damage that occurs – severity
of disease
• Exoenzymes – digest epithelial tissues and permit
invasion of pathogens
• Toxigenicity – capacity to produce toxins at the
site of multiplication
– endotoxins – lipid A of LPS of Gram-negative bacteria
– exotoxins – proteins secreted by Gram-positive and
Gram-negative bacteria
• Antiphagocytic factors – help them to kill or avoid
phagocytes; remain an irritant to host defenses
14
15
16
The Process of Infection and Disease
• 4 distinct stages of clinical infections:
– incubation period - time from initial contact with the
infectious agent to the appearance of first symptoms;
agent is multiplying but damage is insufficient to cause
symptoms; several hours to several years
– prodromal stage – vague feelings of discomfort;
nonspecific complaints
– period of invasion – multiplies at high levels, becomes
well established; more specific signs and symptoms
– convalescent period – as person begins to respond to
the infection, symptoms decline
17
18
Establishment, Spread, and Pathologic
Effects
Patterns of infection:
• Localized infection– microbes enters body and
remains confined to a specific tissue
• Systemic infection– infection spreads to several
sites and tissue fluids usually in the bloodstream
• Focal infection– when infectious agent breaks
loose from a local infection and is carried to other
tissues

19
Patterns of Infection
• Mixed infection – several microbes grow
simultaneously at the infection site -
polymicrobial
• Primary infection – initial infection
• Secondary infection – another infection by a
different microbe
• Acute infection – comes on rapidly, with
severe but short-lived effects
• Chronic infections –progress and persist over
a long period of time
20
21
Signs and Symptoms
• Sign – objective evidence of disease as
noted by an observer
– fever, septicemia, chest sounds, rash,
leukocytosis, antibodies
• Symptom – subjective evidence of disease
as sensed by the patient
– chills, pain, ache, nausea, itching, headache.
fatigue

22
Signs and Symptoms of Inflammation
• Earliest symptoms of disease as a result of
the activation of the body defenses
– fever, pain, soreness, swelling
• Signs of inflammation:
– edema - accumulation of fluid,
– granulomas and abscesses – walled-off
collections of inflammatory cells and microbes
– lymphadenitis – swollen lymph nodes

23
Signs of Infection in the Blood
• Changes in the number of circulating white
blood cells
– leukocytosis – increase in white blood cells
– leukopenia – decrease in white blood cells
– septicemia – microorganisms are multiplying in
the blood and present in large numbers
• bacteremia – small numbers of bacteria present in
blood not necessarily multiplying
• viremia – small number of viruses present not
necessarily multiplying

24
Infections That Go Unnoticed
• Asymptomatic (subclinical) infections –
although infected, the host doesn’t show
any signs of disease
• Inapparent infection, so person doesn’t seek
medical attention

25
Portals of Exit
• Pathogens depart by a specific avenue;
greatly influences the dissemination of
infection
– respiratory – mucus, sputum, nasal drainage,
saliva
– skin scales
– fecal exit
– urogenital tract
– removal of blood

26
Persistence of Microbes and
Pathologic Conditions
• Apparent recovery of host does not always mean the
microbe has been removed.
• Latency – after the initial symptoms in certain chronic
diseases, the microbe can periodically become active
and produce a recurrent disease; person may or may
not shed it during the latent stage
• Chronic carrier – person with a latent infection who
sheds the infectious agent
• Sequelae – long-term or permanent damage to tissues
or organs
27
Reservoirs: Where Pathogens Persist
• Reservoir – primary habitat of pathogen in
the natural world
– human or animal carrier, soil, water, plants
• Source – individual or object from which
an infection is actually acquired

28
Living Reservoirs
• Carrier – an individual who inconspicuously
shelters a pathogen and spreads it to others; may
or may not have experienced disease due to the
microbe
• Asymptomatic carrier –
– incubation carriers – spread the infectious agent
during the incubation period
– convalescent carriers – recuperating without
symptoms
– chronic carrier – individual who shelters the
infectious agent for a long period
• Passive carrier – contaminated healthcare
provider picks up pathogens and transfers them to
other patients
29
30
Animals as Reservoirs and Sources
• A live animal (other than human) that transmits an
infectious agent from one host to another is called
a vector.
• Majority of vectors are arthropods – fleas,
mosquitoes, flies, and ticks
• Some larger animals can also spread infection –
mammals, birds, lower vertebrates.
• Biological vectors – actively participate in a
pathogen’s life cycle
• Mechanical vector – not necessary to the life
cycle of an infectious agent and merely transports
it without being infected
31
• An infection indigenous to animals but
naturally transmissible to humans is a
zoonosis.
• Humans don’t transmit the disease to others.
• At least 150 zoonoses exist worldwide;
make up 70% of all new emerging diseases
worldwide.
• Impossible to eradicate the disease without
eradicating the animal reservoir
32
Nonliving Reservoirs
• Soil, water, and air

33
Acquisition and Transmission of
Infectious Agents
• Communicable disease – when an infected host
can transmit the infectious agent to another host
and establish infection in that host
• Highly communicable disease is contagious.
• Non-communicable infectious disease does not
arise through transmission from host to host.
– occurs primarily when a compromised person is
invaded by his or her own normal microflora
– contact with organism in natural, non-living reservoir

34
Patterns of Transmission
• Direct contact – physical contact or fine
aerosol droplets
• Indirect contact – passes from infected host
to intermediate conveyor and then to
another host
– vehicle – inanimate material, food, water,
biological products, fomites
– airborne – droplet nuclei, aerosols

35
36
Nosocomial Infections
• Diseases that are acquired or developed during a
hospital stay
• From surgical procedures, equipment, personnel, and
exposure to drug-resistant microorganisms
• More than 1/3rd of nosocomial infections could be
prevented.
• 2 to 4 million cases/year in U.S. with approximately
90,000 deaths
• Most commonly involve urinary tract, respiratory tract,
and surgical incisions
• Most common organisms involved: Gram-negative
intestinal flora
– E. coli, Pseudomonas, Staphylococcus
37
38
Universal Blood and Body Fluid
Precautions
• Stringent measures to prevent the spread of
nosocomial infections from patient to
patient, from patient to worker, and from
worker to patient – universal precautions
• Based on the assumption that all patient
specimens could harbor infectious agents,
so must be treated with the same degree of
care
39
Epidemiology
• The study of the frequency and distribution of
disease and health-related factors in human
populations
• Surveillance –collecting, analyzing, and reporting
data on rates of occurrence, mortality, morbidity
and transmission of infections
• Reportable, notifiable diseases must be reported to
authorities.

40
• Centers for Disease Control and Prevention
(CDC) in Atlanta, GA – principal
government agency responsible for keeping
track of infectious diseases nationwide
• http://www.cdc.gov

41
Frequency of Cases
• Prevalence – total number of existing cases
with respect to the entire population usually
represented by a percentage of the
population
• Incidence – measures the number of new
cases over a certain time period, as
compared with the general healthy
population

42
• Mortality rate – the total number of deaths
in a population due to a certain disease
• Morbidity rate – number of people
afflicted with a certain disease

43
• Endemic – disease that exhibits a relatively
steady frequency over a long period of time
in a particular geographic locale
• Sporadic – when occasional cases are
reported at irregular intervals
• Epidemic – when prevalence of a disease is
increasing beyond what is expected
• Pandemic – epidemic across continents

44
45
Koch’s Postulates
Determining the causative or etiologic agent of
infectious disease:
• Find evidence of a particular microbe in every
case of a disease.
• Isolate that microbe from an infected subject and
cultivate it artificially in the laboratory.
• Inoculate a susceptible healthy subject with the
laboratory isolate and observe the resultant
disease.
• Reisolate the agent from this subject.

46

You might also like